Gyeongsangbuk-do, South Korea

Ji-Suk Yun

This inventor holds 1 USPTO granted patent. Top assignee: Samchully Pharm. Co.,ltd.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ji-Suk Yun. Retrieved from https://idiyas.com/inventor/ji-suk-yun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ji-Suk Yun: Innovator in the Preparation of 2-Deoxy-L-Ribose

Introduction

Ji-Suk Yun is a notable inventor based in Gyeongsangbuk-do, South Korea. He has made significant contributions to the field of chemistry, particularly in the preparation of specialized sugars. His innovative methods have implications in various scientific and medical applications.

Latest Patents

Ji-Suk Yun holds a patent for a method of preparing 2-deoxy-L-ribose. This preparation method involves several intricate steps, including treating L-arabinose with an alcohol solvent in the presence of an acid, and subsequently brominating and hydrolyzing the resulting compounds. His patent showcases a detailed process that enhances the efficiency of producing this important sugar.

Career Highlights

Ji-Suk Yun is associated with Samchully Pharm. Co., Ltd., where he applies his expertise in pharmaceutical research and development. His work has contributed to advancements in the production of essential compounds used in various medical applications.

Collaborations

Throughout his career, Ji-Suk Yun has collaborated with esteemed colleagues such as Seung-Bum Ha and Jae-Hoon Jeon. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ji-Suk Yun's contributions to the field of chemistry, particularly through his patent on the preparation of 2-deoxy-L-ribose, highlight his role as an influential inventor. His work continues to impact the pharmaceutical industry and advance scientific knowledge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…